| | | LEVOMEFOLATE CALCIUM
CAS:151533-22-1
Formula: C20H23CaN7O6
PR151533221
497.52
Calcium(S)-2-(4-((((S)-2-aMino-5-Methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)Methyl)aMino)benzamido)-4-carboxybutanoate;N-(4-(((2-Amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamicacidcalciumsalt;L- LEVOMEFOLIC ACID
CAS:31690-09-2
Formula: C20H25N7O6
PR31690092
459.46
N-[4-[[[(6S)-2-Amino-5-methyl-1,4,5,6,7,8-hexahydro-4-oxopteridine-6-yl]methyl]amino]benzoyl]-L-glutamicacid;(S)-N-[4-[[(2-Amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamicacid; LEVOMEFOLIC ACID-13C,D3
CAS:1356019-94-7
Trade Name: (2S)-2-[[4-[[(6S)-2-amino-4-oxo-5-(trideuterio(1^{13}C)methyl)-1,6,7,8-tetrahydropteridin-6-yl]methy
Formula: 13CC192H3H22N7O6
APS1356019947
463.47
(6S)-5-(Methyl-13C,d3)tetrahydrofolic acid, Levomefolic acid (N-methyl-13C,d3),N-[4-[[[(6S)-2-Amino-3,4,5,6,7,8-hexahydro-5-(methyl-13C,d3)-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-L-glutamic acid, l-N5-(Methyl-13C,d3)-L-tetrahydrofolic aci LEVONORGESTREL
CAS:797-63-7
Trade Name: (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocycl
Formula: C21H28O2
PR797637
312.4
NORGESTREL LEVONORGESTREL
CAS:797-63-7
Trade Name: (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocycl
Formula: C21H28O2
ACM797637
312.45
microluton; Levonorgestrel; Levonorgestrel; Norgeston; Microval; [3H]-Levonorgestrel; norplant2; levonova; Levonelle; follistrel; Microlut; postinor; wy-5104; LEVONORGESTREL
CAS:797-63-7
Trade Name: (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocycl
Formula: C21H28O2
APS797637
312.45
Levonova, Mirena, 17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol, D-(-)-Norgestrel, Norlevo, 19-Nortestosterone, 17-ethynyl-18-methyl-, 13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one, Lng-IUS, D-Norgestrel, Norplant II, (17alpha)-1 LEVONORGESTREL ACETATE
CAS:13732-69-9
Trade Name: [(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopen
Formula: C23H30O3
ACM13732699
354.482500 [g/mol]
Norgestrel acetate, 3-Ketonorgestimate, Levonorgestrel acetate, AC1L1Y3V, UNII-VF642934XZ, 18,19-Dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, (17alpha)-(+-)-, [(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-oxo-1,2,6,7,8,9,10,11,12 Levonorgestrel for system suitability 1
CAS:797-63-7
Trade Name: (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocycl
Formula: C21H28O2
APS797637B
312.45
Norplant, 13-Ethyl-17-ethynyl-17beta-hydroxy-4-gonen-3-one, 13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one, Dexnorgestrel, 13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one, 17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one, Lev LEVONORGESTREL FOR SYSTEM SUITABILITY 2
CAS:797-63-7
Trade Name: (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocycl
Formula: C21H28O2
APS797637A
312.45
Norgeston, Microlut, Norplant 2, 18-Methyl-17alpha-ethynyl-19-nortestosterone, d-(17alpha)-17-Hydroxy-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one, Postinor 2, Norplant II, D-(-)-Norgestrel, 13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one, ( LEVONORGESTREL IMPURITY B
CAS:19914-67-1
Trade Name: (8R,9S,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopent
Formula: C21H28O2
APS19914671
312.45
Levonorgestrel Imp. B (EP), 13-Ethyl-17+¦-ethynyl-17-hydroxygon-5(10)-en-3-one, 18,19-Dinor-17+¦-pregn-5(10)-en-20-yn-3-one, 13-ethyl-17-hydroxy- (7CI,8CI),(17+¦)-13-ethyl-17-hydroxy-18,19-Dinorpregn-5(10)-en-20-yn-3-one LEVOPIMARIC ACID
CAS:79-54-9
Trade Name: (1R,4aR,4bS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,9,10,10a-octahydrophenanthrene-1-carboxylic
Formula: C20H30O2
APS79549
302.45
l-Sapietic acid, +¦-Pimaric acid, L-Pimaric acid, 13-Isopropylpodocarpa-8(14),12-dien-15-oic acid, NSC 4827, Podocarpa-8(14),12-dien-15-oic acid, 13-isopropyl- (8CI), l-Pimaric acid, (-)-Levopimaric acid, Levopimaric acid, +ö6,8(14)-Abietadie LEVOPIMARIC ACID
CAS:79-54-9
Trade Name: (1R,4aR,4bS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,9,10,10a-octahydrophenanthrene-1-carboxylic
Formula: C20H30O2
FFC-AR-79549
302.45
(1R,4+¦S,4+¦R)-1,4+¦-Dimethyl-7-propan-2-yl-2,3,4,4+¦,5,9,10,10+¦-octahydro phenanthrene-1-carboxylic acid LEVOSULPIRIDE
CAS:23672-07-3
Trade Name: N-[[(2S)-1-Ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
Formula: C15H23N3O4S
APS23672073A
341.43
(-)-Sulpiride, S-(-)-Sulpiride, o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-, (-)- (8CI), Levobren, l-Sulpiride,5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxybenzamide, sulpid, L-Sulpiride, S-Sulpiride, LEWIS A TRISACCHARIDE,METHYL GLYCOSIDE
CAS:186315-40-2
Trade Name: N-[(2R,3R,4R,5S,6R)-6-(hydroxymethyl)-2-methoxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethy
Formula: C21H38NO15
ACM186315402
544.54
Methyl 2-Acetamido-2-deoxy-4-O-(+¦-L-fucopyranosyl)-3-O-(b-D- galactopyranosyl)-b-D-glucopyranoside, Gal1-b-3[Fuc1-+¦-4]GlcNAc1-b-O-Me LEWIS X TRISACCHARIDE
CAS:71208-06-5
Trade Name: N-[(2R,3R,4R,5R)-5,6-dihydroxy-1-oxo-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl
Formula: C20H35NO15
ACM71208065
529.49
Gal+¦1, 4(Fuc+¦1, 3)GlcNAc LEWIS X TRISACCHARIDE
CAS:71208-06-5
Trade Name: N-[(2R,3R,4R,5R)-5,6-dihydroxy-1-oxo-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl
Formula: C20H35NO15
BBC71208065
529.49
Gal+¦1, 4(Fuc+¦1, 3)GlcNAc LEWIS X TRISACCHARIDE
CAS:71208-06-5
Trade Name: N-[(2R,3R,4R,5R)-5,6-dihydroxy-1-oxo-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl
Formula: C20H35NO15
DS71208065
529.49 g/mol
Lewis X LEWIS Y TETRASACCHARIDE
CAS:82993-43-9
Trade Name: N-[(3R,4R,5S,6R)-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5R,6R)-3,4,5-trihy
Formula: C26H45NO19
ACM82993439
675.64
Fuc+¦1, 2Gal+¦1, 4 (Fuc+¦1, 3)GlcNAc LEWIS Y TETRASACCHARIDE
CAS:82993-43-9
Trade Name: N-[(3R,4R,5S,6R)-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5R,6R)-3,4,5-trihy
Formula: C26H45NO19
BBC82993439
675.64
Fuc+¦1, 2Gal+¦1, 4 (Fuc+¦1, 3)GlcNAc LG 100268
CAS:153559-76-3
Formula: C24H29NO2
ACM153559763
363.49
Lg 100268;6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-cyclopropyl]-nicotinic acid;6-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)cyclopropyl]-3-pyridinecarboxylic acid LGALS1 Protein, Human, Recombinant (His)
RHC-OTH-0262
15 kDa (reducing condition)
+¦-Galactoside-Binding Lectin L-14-I, S-Lac Lectin 1, Putative MAPK-Activating Protein PM12, LG, Lectin Galactoside-Binding Soluble 1, Lactose-Binding Lectin 1, HPL, HLBP14, HBL, Galectin-1, Galaptin, Gal-1, Beta-Galactoside-Binding Lectin L LHRH II
CAS:91097-16-4
Trade Name: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamo
Formula: C60H69N17O13
ACM91097164
1236.295960 [g/mol]
Cgnrh-II, Clhrh II, Gnrh-II, GNRH, Chicken II, LHRH-II, Chicken, LHRH-II, 5-His-7-trp-8-tyr-LHRH, His(5)-trp(7)-tyr(8)-gnrh, GNRH, his(5)-trp(7)-tyr(8)-, LHRH, his(5)-trp(7)-tyr(8)-, 5-Histidyl-7-tryptophyl-8-tyrosine-LHRH, p-Glu-his-trp-se LIANGSHANIN A
CAS:122717-54-8
Trade Name: (1R,2R,4S,9R,10S,13S,16R)-2,16-dihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]
Formula: C20H26O4
ACM122717548
330.4 LICOAGROCHALCONE A
CAS:202815-28-9
Trade Name: (E)-1-(2,4-dihydroxyphenyl)-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one
Formula: C20H20O4
ACM202815289
324.370400 [g/mol]
licoagrochalcone A, CHEMBL229885, LICOAGROCHALCONEA, SCHEMBL632907, DNC007424, LMPK12120068, 3-Prenyl-4,2,4-trihydroxychalcone, 202815-28-9 LICOFELONE
CAS:156897-06-2
Trade Name: 2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic acid
Formula: C23H22ClNO2
APS156897062
379.88
Licofelone,1H-Pyrrolizine-5-acetic acid, 6-(4-chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl-, ML 3000, [2,2-Dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid LICORICESAPONIN A3
CAS:118325-22-7
Trade Name: (2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-4,4,6a,6b,8a,11,14b
Formula: C48H72O21
ACM118325227
985.07 LICORICESAPONIN G2
CAS:118441-84-2
Trade Name: (2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6S)-2-[[(3S,4S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4-(hy
Formula: C42H62O17
ACM118441842
838.93 Licoricesaponin H2(18Beta,20Alpha-Glycyrrhizic Acid)
CAS:118441-85-3
Trade Name: (2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11R,12aR,14aR,14bS)-11-carboxy-4,4,6a,6
Formula: C42H62O16
ACM118441853
822.92 LIDAMIDINE HYDROCHLORIDE
CAS:65009-35-0
Trade Name: 1-(2,6-dimethylphenyl)-3-(N-methylcarbamimidoyl)urea;hydrochloride
Formula: C11H16N4O.ClH
APS65009350
256.73
Lidamidine Hydrochloride,N-(2,6-Dimethylphenyl)-N'-[imino(methylamino)methyl]urea Hydrochloride (1:1), Urea, N-(2,6-dimethylphenyl)-N'-[imino(methylamino)methyl]-, monohydrochloride (9CI), Smodin, WHJR 1142A, Lidarral, WHR 1142A LIDOFLAZINE
CAS:3416-26-0
Trade Name: 2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]-N-(2,6-dimethylphenyl)acetamide
Formula: C30H35F2N3O
APS3416260
491.62
McN-JR 7904, Corflazine, 4-[4,4-Bis(p-fluorophenyl)butyl]-1-piperazineaceto-2',6'-xylidide, 1-[4,4-Bis(fluorophenyl)butyl]-4-(2,6-dimethylanilinocarbonylmethyl)piperazine, Lidoflazine, Ordiflazine, Clinium, R 7904, Angex, Lidoflazinum, 1-[4 LIDOFLAZINE,98.5%
CAS:3416-26-0
Formula: C30H35F2N3O
ACM3416260
491.622
1-(4,4-bis(4-fluorofenil)butil)-4-((2,6-dimetilanilinocarbonil)metil)piperaz;1-piperazineacetamide,4-(4,4-bis(4-fluorophenyl)butyl)-n-(2,6-dimethylphenyl;4-(4,4-bis(p-fluorophenyl)butyl)-1-piperazineaceto-2',6'-xylidide;6'-xylidide,4-(4,4-b LIFITEGRAST
CAS:1025967-78-5
Formula: C29H24Cl2N2O7S
ACM1025967785
0
lifitegrast;Lifitegrast, SAR 1118;L-Phenylalanine,N-[[2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-;N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]ca LIGHT STABILIZER 944
CAS:70624-18-9
ACM70624189-1
1,6-Hexanediamine,N,N'-bis(2,2,6,6-tetramethyl-4-piperidinyl)-,polymerwith2,4,6-trichloro-1,3,5-triazine,reactionproductswith2,4,4-trimethyl-2-pentanamine LIGHT STABILIZER UV-3529
CAS:193098-40-7
Formula: (C33H60N80)n
ACM193098407
N,N'-Bis(2,2,6,6-tetramethyl-4-piperidinyl)-1,6-hexanediamine polymers with morpholine-2,4,6-trichloro-1,3,5-triazine reaction products, methylated;Light Stabilizer UV-3529;1,6-Hexanediamine, N,N'-bis(2,2,6,6-tetramethyl-4-piperidinyl)-, po Lignan P Phosphate
Trade Name: [4-[(5S,5aR,8aR,9R)-8-oxo-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl
Formula: C27H31O16P
APS009429
642.50
(5R,5aR,8aR,9S)-9-(+¦-D-Glucopyranosyloxy)-5-(4-(phosphonooxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydro[2]benzofuro-[5,6-f][1,3]benzodioxol-6(5aH)-one LIGUCYPERONOL
CAS:105108-20-1
Trade Name: (4R,4aR,7R)-4-hydroxy-1,4a-dimethyl-7-prop-1-en-2-yl-3,4,5,6,7,8-hexahydronaphthalen-2-one
Formula: C15H22O2
ACM105108201
234.3
2(3H)-Naphthalenone, 4,4A,5,6,7,8-Hexahydro-4-Hydroxy-1,4A-Dimethyl-7-(1-Methylethenyl)-, (4R,4Ar,7R)- LIGUSTROFLAVONE
CAS:260413-62-5
Trade Name: 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2R
Formula: C33H40O18
BBC260413625
724.67
Nuezhenoside LIGUSTROFLAVONE
CAS:260413-62-5
Trade Name: 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2R
Formula: C33H40O18
ACM260413625
724.67
Nuezhenoside LILRA3/CD85e Protein, Human, Recombinant (His & Avi)
RHC-CD-2065
47.9 kDa (predicted). Due to glycosylation, the pr
LIR-4HM43e3, LIR4, LILRA3, ILT-6, ILT6, HM43, HM31, CD85e LILRA3/CD85e Protein, Human, Recombinant (His), Biotinylated
RHC-CD-2052
46.5 kDa (predicted)
LIR-4, LIR4, leukocyte immunoglobulin like receptor A3, ILT-6, ILT6, HM43, HM31, CD85e LILRA5/CD85f/ILT11 Protein, Human, Recombinant (hFc)
RHC-CD-0655
52 kDa (predicted)
LIR-9, LIR9, LILRB7, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5, ILT-11, ILT11, CD85F, CD85 LILRA5/CD85f/ILT11 Protein, Human, Recombinant (His & Avi)
RHC-CD-0761
28.2 kDa (predicted). Due to glycosylation, the pr
LIR-9, LIR9, LILRB7, LILRA5, ILT11CD85f, ILT-11, ILT11, CD85f, CD85 LILRA5/CD85f/ILT11 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0733
28.5 kDa (predicted)
LIR-9, LIR9, LILRB7, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5, ILT-11, ILT11, CD85F, CD85 LILRA5/CD85f/ILT11 Protein, Human, Recombinant (His)
RHC-CD-0594
26.7 kDa (predicted)
LIR-9, LIR9, LILRB7, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5, ILT-11, ILT11, CD85F, CD85 LILRB1/CD85j/ILT2 Domain1 & 2 Protein, Human, Recombinant (His)
RHC-CD-2197
23.1 kDa (predicted). Due to glycosylation, the pr
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB1/CD85j/ILT2 Protein, Cynomolgus, Recombinant (His)
RHC-CD-2351
48.19 kDa (predicted). Due to glycosylation, the p
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB1/CD85j/ILT2 Protein, Human, Recombinant (aa 116-461, His)
RHC-CD-2060
38.15 kDa (predicted). Due to glycosylation, the p
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB1/CD85j/ILT2 Protein, Human, Recombinant (aa 24-458, hFc)
RHC-CD-2196
73.8 kDa (predicted). Due to glycosylation, the pr
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB1/CD85j/ILT2 Protein, Human, Recombinant (aa 24-458, His & Avi), Biotinylated
RHC-CD-2349
50 kDa (predicted). Due to glycosylation, the prot
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB1/CD85j/ILT2 Protein, Human, Recombinant (hFc)
RHC-CD-1825
73.9 kDa (predicted); 107.6 kDa (reducing conditio
XXbac-BCX85G21.4, MIR-7, MIR7, LIR-1, LIR1, leukocyte immunoglobulin like receptor B1, ILT-2, ILT2, CD85j LILRB1/CD85j/ILT2 Protein, Human, Recombinant (His & Avi)
RHC-CD-2025
50 kDa (predicted). Due to glycosylation, the prot
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB1/CD85j/ILT2 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-2954
50.47 kDa (predicted); 75.5 kDa (reducing conditio
XXbac-BCX85G21.4, MIR-7, MIR7, LIR-1, LIR1, leukocyte immunoglobulin like receptor B1, ILT-2, ILT2, CD85j LILRB1/CD85j/ILT2 Protein, Human, Recombinant (His)
RHC-CD-2095
48.6 kDa (predicted); 61-68 kDa (reducing conditio
XXbac-BCX85G21.4, MIR-7, MIR7, LIR-1, LIR1, leukocyte immunoglobulin like receptor B1, ILT-2, ILT2, CD85j LILRB1/CD85j/ILT2 Protein, Human, Recombinant (mFc)
RHC-CD-2350
73.5 kDa (predicted). Due to glycosylation, the pr
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB1/CD85j/ILT2 Protein, Rhesus macaque, Recombinant (aa 1-474, hFc)
RHC-CD-1889
75.2 kDa (predicted). Due to glycosylation, the pr
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB1/CD85j/ILT2 Protein, Rhesus macaque, Recombinant (aa 17-456, hFc)
RHC-CD-2208
74.5 kDa (predicted). Due to glycosylation, the pr
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB1/CD85j/ILT2 Protein, Rhesus macaque, Recombinant (His)
RHC-CD-2474
48.08 kDa (predicted). Due to glycosylation, the p
XXbac-BCX85G21.4, MIR7, LIR1, LILRB1, ILT2FLJ37515, ILT-2, ILT2, CD85J LILRB2/CD85d/ILT4 Protein, Human, Recombinant (Avi & His), Biotinylated
RHC-CD-3584
60-80 kDa (reducing condition)
Monocyte/Macrophage Immunoglobulin-Like Receptor 10, MIR-10, LIR-2, Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2, Leukocyte Immunoglobulin-Like Receptor 2, L, Immunoglobulin-Like Transcript 4, ILT-4, CD85d, CD85 Antigen-Like LILRB2/CD85d/ILT4 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-3421
50.2 kDa (predicted). Due to glycosylation, the pr
MIR10, LIR2, LILRB2, ILT4CD85d, ILT-4, ILT4, CD85d LILRB3/CD85a Protein, Human, Recombinant (hFc)
RHC-CD-0659
72.9 kDa (predicted)
XXbac-BCX105G6.7, PIRB, MGC138403, LIR-3, LIR3, LILRA6, leukocyte immunoglobulin like receptor B3, ILT-5, ILT5, HL9, CD85A LILRB3/CD85a Protein, Human, Recombinant (His & Avi)
RHC-CD-2458
50 kDa (predicted). Due to glycosylation, the prot
PIRB, LIR-3MGC138403, LIR3CD85A, LIR3, LILRB3, ILT-5, ILT5, HL9, CD85a LILRB3/CD85a Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-1907
50 kDa (predicted). Due to glycosylation, the prot
PIRB, LIR-3MGC138403, LIR3CD85A, LIR3, LILRB3, ILT-5, ILT5, HL9, CD85a LILRB3/CD85a Protein, Human, Recombinant (His)
RHC-CD-2403
47.6 kDa (predicted); 55-60 kDa (reducing conditio
XXbac-BCX105G6.7, PIRB, MGC138403, LIR-3, LIR3, LILRA6, leukocyte immunoglobulin like receptor B3, ILT-5, ILT5, HL9, CD85A LILRB3/CD85a Protein, Human, Recombinant (His), Biotinylated
RHC-CD-2159
47.6 kDa (predicted)
XXbac-BCX105G6.7, PIRB, MGC138403, LIR-3, LIR3, LILRA6, leukocyte immunoglobulin like receptor B3, ILT-5, ILT5, HL9, CD85A LIMAPROST
CAS:88852-12-4
Formula: C36H60O30.C22H36O5
ACM88852124
1353.36
17S,20-Dimethyl-trans-D2-PGE1 compd. with a-cyclodextrin;2,4,7,9,12,14,17,19,22,24,27,29-Dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane, a-cyclodextrin deriv.;2-Heptenoic acid, 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5S LIMETOL
CAS:7392-19-0
Formula: C10H18O
ACM7392190
154.25
2,2,6-TRIMETHYL-6-VINYLTETRAHYDROPYRAN;FEMA 3735;LIMETOL;2,2,6-Trimethyl-6-vinyltetrahydro-2H-pyran;2,6,6-trimethoxy-2-vinyltetrahydropyran;2,6,6-trimethyl-2-ethenyltetrahydro-2H-pyran;2,6,6-trimethyl-2-ethenyltetrahydropyran;2,6,6-Trimethy LIMETOL
CAS:7392-19-0
Trade Name: 2-Ethenyl-2,6,6-trimethyloxane
Formula: C10H18O
APS7392190
154.25
Pyran, tetrahydro-2,2,6-trimethyl-6-vinyl- (7CI),2H-Pyran, 2-ethenyltetrahydro-2,6,6-trimethyl-, 2H-Pyran, tetrahydro-2,2,6-trimethyl-6-vinyl- (8CI), 2,6,6-Trimethyl-2-vinyltetrahydro-2H-pyran, 2,2,6-Trimethyl-6-vinyltetrahydropyrane, 2,6,6 Limitin Protein, Mouse, Recombinant (His)
RHC-CGF-0028
19 kDa (reducing condition)
Lmtn, Limitin, interferon +¦, interferon zeta, IFN-+¦, IFN-zeta, IFN-z, Ifnz, BGIF LIMONEXIN
CAS:99026-99-0
Trade Name: (1R,2R,7S,10R,13R,14R,16S,19R,20S)-19-(2-hydroxy-5-oxo-2H-furan-3-yl)-9,9,13,20-tetramethyl-4,8,15,1
Formula: C26H30O10
FFC-AR-99026990
502.52
Limonexic acid LIMONIN
CAS:1180-71-8
Trade Name: (1R,2R,7S,10R,13R,14R,16S,19S,20S)-19-(Furan-3-yl)-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo
Formula: C26H30O8
FFC-AR-1180718
470.51
7,16-Dioxo-7,16-dideoxylimondiol LIMONIN
CAS:1180-71-8
Trade Name: (1R,2R,7S,10R,13R,14R,16S,19S,20S)-19-(Furan-3-yl)-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo
Formula: C26H30O8
BBC1180718
470.51
Evodia lactone LIMONIN
CAS:1180-71-8
Trade Name: (1R,2R,7S,10R,13R,14R,16S,19S,20S)-19-(Furan-3-yl)-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo
Formula: C26H30O8
MTL1180718
470.51
Evodia lactone LIMONIN
CAS:1180-71-8
Trade Name: (1R,2R,7S,10R,13R,14R,16S,19S,20S)-19-(Furan-3-yl)-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo
Formula: C26H30O8
ACM1180718
470.51
Evodia lactone LIMONIN
CAS:1180-71-8
Trade Name: (1R,2R,7S,10R,13R,14R,16S,19S,20S)-19-(Furan-3-yl)-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo
Formula: C26H30O8
ACM1180718
470.51
Evodia lactone Limonin, food grade
CAS:1180-71-8
Trade Name: (1R,2R,7S,10R,13R,14R,16S,19S,20S)-19-(Furan-3-yl)-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo
Formula: C26H30O8
DS1180718
470.53
Limonoate D-ring-lactone; Limonoic acid di-delta-lactone LIMPII/SR-B2 Protein, Human, Recombinant (hFc)
RHC-RP-2950
73.26 kDa (predicted)
SR-BII, scavenger receptor class B, member 2, LIMPII, LIMP-2, LGP85, HLGP85, EPM4, CD36L2, AMRF LIMPII/SR-B2 Protein, Human, Recombinant (His & hFc)
RHC-RP-2683
74.4 kDa (predicted); 110-115 kDa (reducing condit
SR-BII, scavenger receptor class B, member 2, LIMPII, LIMP-2, LGP85, HLGP85, EPM4, CD36L2, AMRF LINACLOTIDE
CAS:851199-59-2
Trade Name: (2S)-2-[[(1R,4S,7S,13S,16R,21R,24R,27S,30S,33R,38R,44S)-21-amino-13-(2-amino-2-oxoethyl)-27-(2-carbo
Formula: C59H79N15O21S6
PR851199592
1526.8
Linzess LINACLOTIDE ACETATE
CAS:851199-60-5
Trade Name: (2S)-2-[[(1R,4S,7S,13S,16R,21R,24R,27S,30S,33R,38R,44S)-21-amino-13-(2-amino-2-oxoethyl)-27-(2-carbo
Formula: C61H83N15O23S6
CDMO851199605
1586.80
L-Tyrosine LINADRYL
CAS:525-01-9
Trade Name: 4-(2-benzhydryloxyethyl)morpholine
Formula: C19H23NO2
ACM525019
297.396
Linadryl, beta-Morpholinoethyl benzhydryl ether, CID22215, 4-(2-(Diphenylmethoxy)ethyl)morpholine, BRN 0266743, N-(2-Benzhydryloksy-etylo)morfolina, Morpholine, 4-(2-(diphenylmethoxy)ethyl)-, A-446, LS-92828, N-(2-Benzhydryloksy-etylo)morfo LINAGLIPTIN
CAS:668270-12-0
Trade Name: 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-d
Formula: C25H28N8O2
APS668270120
472.54
ONDERO, Trazenta, Linagliptin,1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-, BI 1356, 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-3,7-dih LINAGLIPTIN ACETAMIDE
CAS:1803079-49-3
Trade Name: N-[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3
Formula: C27H30N8O3
APS1803079493
514.58
(R)-N-(1-(7-(But-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide,N-[(3R)-1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo- Linalool 1000 -¦g/mL in Isopropanol
CAS:78-70-6
Trade Name: 3,7-DIMETHYLOCTA-1,6-DIEN-3-OL
Formula: C10H18O
APS78706
154.25
1,6-Octadien-3-ol, 3,7-dimethyl-, Linalol, 3,7-Dimethyl-3-hydroxy-1,6-octadiene, Phantol, NSC 3789, L 260-2, Linanool, Linalyl alcohol, dl-Linalool, 2,6-Dimethyl-2,7-octadien-6-ol, 3,7-Dimethyl-1,6-octadiene-3-ol, 3,7-Dimethyl-1,6-octadien- |
